Family Management’s MetLife MET Stock Holding History

Family Management’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-96,520	Closed	-$4.15M	–	81
2015 Q4	$4.15M	Buy	+96,520	New	+$4.24M	2.14%	20
2013 Q3	–	Sell	-17,054	Closed	-$696K	–	73
2013 Q2	$696K	Buy	+17,054	New	+$627K	0.42%	49

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Family Management's MET Position: Q1 2016 in Review

Family Management sold out of MetLife (MET) in Q1 2016, closing a stake of 96,520 shares — an estimated $4.15M sold.

Family Management first reported a position in MET in Q2 2013 and held it in 2 quarters. The position peaked at $4.15M in Q4 2015. 971 funds tracked by Wall St. Rank hold MET as of Q1 2016.

Family Management reported no remaining MetLife position as of Q1 2016 after selling out during the quarter.
Family Management sold 96,520 MetLife shares in Q1 2016, an estimated $4.15M.
Family Management first reported a position in MetLife in Q2 2013 and held it in 2 quarters.
Family Management's MetLife position peaked at $4.15M in Q4 2015.
971 funds tracked by Wall St. Rank held MetLife as of Q1 2016.

Based on Family Management's 13F filing for Q1 2016, filed 16 May 2016.